Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Accelerated Communication

  • You have access
    Selective and Potent Inhibition of Human CYP2C19 Activity by a Conformationally Targeted Antipeptide Antibody
    Timothy Schulz-Utermoehl, Richard J. Mountfield, Kjeld Madsen, Peer N. Jørgensen and Kristian T. Hansen
    Drug Metabolism and Disposition July 2000, 28 (7) 715-717;
  • You have access
    3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)
    Olivier Barbier, David Turgeon, Caroline Girard, Mitchell D. Green, Thomas R. Tephly, Dean W. Hum and Alain Bélanger
    Drug Metabolism and Disposition May 2000, 28 (5) 497-502;
  • You have access
    Identification of a Ubiquitination-Target/Substrate-Interaction Domain of Cytochrome P-450 (CYP) 2E1
    Amit Banerjee, Thomas A. Kocarek and Raymond F. Novak
    Drug Metabolism and Disposition February 2000, 28 (2) 118-124;
  • You have access
    Comparison of In Vivo and In VitroDeposition of Rhodamine and Fluorescein in Hair
    Peter R. Stout and James A. Ruth
    Drug Metabolism and Disposition October 1998, 26 (10) 943-948;
  • You have access
    Thiodiglycolic Acid is Excreted by Humans Receiving Ifosfamide and Inhibits Mitochondrial Function in Rats
    Theresa M. Visarius, Heinz Bähler, Adrian Küpfer, Thomas Cerny and Bernhard H. Lauterburg
    Drug Metabolism and Disposition March 1998, 26 (3) 193-196;
  • You have access
    Metabolic Screening Using On-Line Ultrafiltration Mass Spectrometry
    Richard B. van Breemen, Dejan Nikolic and Judy L. Bolton
    Drug Metabolism and Disposition February 1998, 26 (2) 85-90;
  • You have access
    Effect of Common Organic Solvents on in VitroCytochrome P450-Mediated Metabolic Activities in Human Liver Microsomes
    Nathalie Chauret, Annick Gauthier and Deborah A. Nicoll-Griffith
    Drug Metabolism and Disposition January 1998, 26 (1) 1-4;
  • You have access
    Glutathione-Dependent Conversion to Glyoxylate, a Major Pathway of Dichloroacetate Biotransformation in Hepatic Cytosol from Humans and Rats, is Reduced in Dichloroacetate-Treated Rats
    M. O. James, R. Cornett, Z. Yan, G. N. Henderson and P. W. Stacpoole
    Drug Metabolism and Disposition November 1997, 25 (11) 1223-1227;
  • You have access
    Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents
    Phyllissa Schmiedlin-Ren, David J. Edwards, Michael E. Fitzsimmons, Kan He, Kenneth S. Lown, Patrick M. Woster, Atiqur Rahman, Kenneth E. Thummel, Jeannine M. Fisher, Paul F. Hollenberg and Paul B. Watkins
    Drug Metabolism and Disposition November 1997, 25 (11) 1228-1233;
  • You have access
    Human UGT2B7 Catalyzes Morphine Glucuronidation
    Birgit L. Coffman, Gladys R. Rios, Christopher D. King and Thomas R. Tephly
    Drug Metabolism and Disposition January 1997, 25 (1) 1-4;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics